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Abstract
Prostate cancer is one of the major causes of cancer death for men. Magnetic resonance (MR) 
imaging is being increasingly used as an important modality to localize prostate cancer. Therefore, 
localizing prostate cancer in MRI with automated detection methods has become an active area of 
research. Many methods have been proposed for this task. However, most of previous methods 
focused on identifying cancer only in the peripheral zone (PZ), or classifying suspicious cancer 
ROIs into benign tissue and cancer tissue. Few works have been done on developing a fully 
automatic method for cancer localization in the entire prostate region, including central gland 
(CG) and transition zone (TZ). In this paper, we propose a novel learning-based multi-source 
integration framework to directly localize prostate cancer regions from in vivo MRI. We employ 
random forests to effectively integrate features from multi-source images together for cancer 
localization. Here, multi-source images include initially the multi-parametric MRIs (i.e., T2, DWI, 
and dADC) and later also the iteratively-estimated and refined tissue probability map of prostate 
cancer. Experimental results on 26 real patient data show that our method can accurately localize 
cancerous sections. The higher section-based evaluation (SBE), combined with the ROC analysis 
result of individual patients, shows that the proposed method is promising for in vivo MRI based 
prostate cancer localization, which can be used for guiding prostate biopsy, targeting the tumor in 
focal therapy planning, triage and follow-up of patients with active surveillance, as well as the 
decision making in treatment selection. The common ROC analysis with the AUC value of 0.832 
and also the ROI-based ROC analysis with the AUC value of 0.883 both illustrate the effectiveness 
of our proposed method.
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1. Introduction
Prostate cancer is the most commonly diagnosed non-skin cancer and the second leading 
cause of cancer death among U.S. men [1]. Current clinical practice for the diagnosis of 
prostate cancer is often based on a transrectal ultrasound (TRUS) biopsy, after the patient 
shows an elevated serum prostate specific antigen (PSA) level. A large screening trial using 
PSA and TRUS has shown that it is possible to reduce prostate cancer mortality by 20–30% 
[2]. However, these studies have also shown that PSA testing in combination with TRUS 
biopsies has a relatively low specificity. Additionally, cancer is often under-graded in TRUS 
biopsies [3]. These problems lead to over-diagnosis and overtreatment of patients for 
prostate cancer [4]. Alternatively, multi-parametric high-contrast magnetic resonance (MR) 
imaging provides a powerful and noninvasive imaging tool for detecting suspicious 
cancerous tissues [5], as shown in Fig. 1, which includes T2, diffusion-weighted (DW) 
imaging (DWI) and apparent diffusion coefficient (ADC) MR images. Since ADC MR 
image is calculated from DWI and related to the b-value, in our experiments, only one type 
of ADC MR image – dADC (the regular ADC map) – is used.
Nowadays, MRI is often used as a second line modality after repeating negative TRUS 
biopsies. One of the reasons why MRI has not yet progressed to the first line modality for 
prostate cancer diagnosis is mainly the need of high-level expertise of radiologist to read 
prostate MRI. Such expertise is not widely available [6,7]. Besides, the MRI-based diagnosis 
suffers from large observer variability due to the difficulty of the task [7]. Additionally, due 
to the large number of 3D images, reading prostate MRI data is quite time-consuming and 
labor-intensive.
Automated computer-aided detection and diagnosis (CAD) of prostate cancer could help 
reduce the above problems and open the door to prostate cancer screening using multi-
parametric MRIs. In the recent decade, computer-aided detection and diagnosis of prostate 
cancer is becoming an active field of research and many methods have been proposed [6,8–
16]. However, there are still some limitations for the previous works:
1. Prostate consists of several main regions, namely peripheral zone (PZ), central 
gland (CG), and transition zone (TZ). In MR images, cancer in the PZ has richer 
textural information than that in the CG [17], which makes the computer-aided 
detection relatively easy in the PZ. Therefore, early researches of MRI-based 
prostate cancer detection mainly focused on identification of cancer only in the 
PZ, instead of the entire prostate region. For example, Chan et al. [10] were the 
first to implement the prostate cancer detection method by using multi-
parametric MRIs. In their paper, they used the SVM classifier to identify prostate 
cancer in the PZ by combining information from three different MRI techniques: 
T2-weighted (T2W), T2-mapping, and line scan diffusion imaging (LSDI). Niaf 
et al. [8,14] and Vos et al. [9] proposed machine-learning methods for suspicious 
region of interest (ROI) classification in the PZ. In addition, many techniques 
have also been developed in the imaging field to facilitate image-guided prostate 
cancer detection in the PZ. For example, Langer et al. [15] developed a multi-
parametric model suitable for prospectively identifying prostate cancer in the PZ 
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by using MRI. However, many studies have demonstrated that prostate cancer is 
not limited to the PZ, but also appears in the CG [11,12,16] and TZ [18,19]. But, 
identifying TZ tumor is a difficult task [20] since the TZ is the site of origin of 
benign prostatic hyperplasia (BPH), which can have a heterogeneous appearance 
[21,22].
2. In the literature, prostate cancer is usually detected via a two-stage CAD system. 
In the first stage, the suspicious cancer ROIs are manually delineated by 
radiologist. In the second stage, those suspicious ROIs are classified into benign 
and cancer tissues by using textual information within those ROIs. Most of these 
two-stage CAD systems are semi-automatic, as the suspicious cancer ROIs often 
have to be delineated manually by radiologist, which is labor-intensive, time-
consuming, and subject to manual errors. For example, Niaf et al. [8,14] 
proposed a CAD system, aimed to separate cancer ROIs from benign ROIs by 
using supervised learning methods. In their methods, suspicious cancer ROIs 
were manually delineated by two persons, i.e., one histopathologist and one 
researcher, by using histological sections as gold standard. Compared with these 
two-stage methods, our proposed method directly localizes cancer regions voxel-
by-voxel, similar to the detection systems proposed by Tiwari et al. [23] and 
Sparks and Madabhushi [24], thus is able to detect much smaller cancer regions. 
This aspect is important to guide prostate biopsy, as well as precisely target the 
tumor in focal therapy planning. Besides, our method is fully automatic and also 
computationally efficient.
3. There are still a few works that classify the whole prostate region into benign or 
malignant tissues, especially in the early diagnosis of prostate cancer. Firjani et 
al. [13] used DWI and a KNN-based classifier to classify the prostate into benign 
or malignant regions based on three appearance features extracted from the 
registered ADC images with different b-values. With their methods, prostate with 
malignant or benign cancer could be discriminated, but the identified cancer 
regions were too coarse to guide prostate biopsy. In other words, such method 
only focused on determining whether cancer exists in the prostate, which cannot 
be adopted for guiding prostate biopsy that needs more accurate cancer 
localization.
Litjens et al. [25] proposed an automated zone-specific CAD pipeline for prostate cancer 
detection. They mainly used an atlas-based method to segment the prostate into PZ and TZ. 
Then, they detected cancer from each zone. Recently, they [6] again proposed a novel and 
fully automatic CAD system to detect prostate cancer. Similar to the method in [25], in the 
first stage of their method, for detecting the candidate regions, they used a multi-atlas-based 
prostate segmentation, three different voxel classifiers (by integrating various features such 
as intensity, pharmacokinetic, texture, blobness and anatomical features from multi-
parametric MRIs), as well as local maxima detection. Then, in the second stage, the statistics 
(of voxel-wise features), local contrast, symmetry, and shape features were extracted as 
candidate representations and further input to a classifier for both cancer ROI identification 
and segmentation. Finally, with lesion-based FROC and patient-based ROC analysis, their 
system showed a reasonable performance in prostate cancer detection.
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Inspired by these existing methods, T2, DWI, and ADC map are used in our work for 
prostate cancer localization. As demonstrated in the literature, by combining any two of 
three multi-parametric MRIs, prostate cancer regions can be more effectively discriminated 
from non-cancerous regions. For instance, Miao et al. [26] found that the performance of 
DW imaging in prostate cancer detection was significantly better than that of T2W imaging. 
Shimofusa et al. [27] compared the prostate cancer detection ability of T2W imaging 
without or with DW imaging. Morgan et al. [28] compared the performance of prostate 
cancer detection by using T2W alone, and also jointly using T2W and DWI or ADC map. In 
their works, by analyzing the statistical results, they concluded that, compared with the cases 
of using T2W without or with ADC map, using T2W with DWI had the superiority in cancer 
detection. All these methods were based on medical statistical analysis, and their results 
reported in the papers demonstrated that multi-parametric MRIs provided better information 
about cancerous and normal regions in the prostate, when compared to the methods using a 
single MRI modality. This was similarly verified by Ozer et al. [29].
To deal with the aforementioned limitations of previous works, in this paper, we propose a 
novel learning-based multi-source integration framework, similar to the method proposed by 
Montillo [30], for accurate localization of prostate cancer within the entire prostate. 
Specifically, in our method, we first employ random forests [31] to train a classifier based on 
the training subjects with multi-parametric MRIs (T2, DWI, and dADC, as shown in Fig. 1). 
The trained classifier provides an initial cancer probability map for each training subject. 
Then, inspired by auto-context model [32,33], the estimated tissue probability map is further 
used as additional source of information to train the next classifier, which integrates the 
high-level context features (from the estimated cancer probability map) with the appearance 
features (from multi-parametric MRIs) for refining cancer classification. By iteratively 
training the classifiers based on the updated cancer probability map (and the multi-
parametric MRIs), we can finally obtain a sequence of classifiers. Similarly, in the 
application stage, given a target subject, the learned classifiers are sequentially applied to 
iteratively refine the estimation of cancer probability map by combining the multi-
parametric MRI information with the previously-estimated cancer probability map. We have 
validated our proposed method on 26 patient subjects, with promising performance.
The rest of the paper is organized as follows. A detailed description of source images and 
our proposed method are introduced in Section 2. Experimental design, results and analysis 
are then presented in Section 3, followed by the Discussions and Conclusion sections.
2. Materials and method
2.1. Data and image preprocessing
In our work, all patients underwent prostatectomy and preoperative multi-parametric 
endorectal MR imaging, including all sequences of T2W and DW MR imaging in the axial 
direction with Philips MR scanners (Achieva; Philips Healthcare, Eindhoven, the 
Netherlands, a 3T imager) between March 2008 and March 2010, and have not been 
previously treated before (such as with radiation or hormone). ADC values were calculated 
from DW MR images by using a linear least squares [34] fitting to the logarithmic form of a 
mono-exponential DW signal model, as follows:
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(1)
where S0 and Sb are the DW MR signal intensities with diffusion weighting of 0 and b, 
respectively [35–37]. Here, we use one kind of ADC image – dADC image – as a source 
image for cancer localization as shown in Fig. 1. Multi-parametric MRI data (T2, DWI and 
dADC) from 26 patients are included in this study. Among 26 subjects, there are totally 42 
tumors, including 29 PZ tumors, 7 CG tumors and 6 TZ tumors.
All MR images were acquired with an endorectal coil (Medrad; Bayer Healthcare, 
Warrendale, PA) and a phased-array surface coil with the aforementioned Philips MR 
scanners. Immediately before MR imaging, 1 mg of glucagon (Glucagon; Lilly, 
Indianapolis, Ind) was injected intramuscularly to decrease peristalsis of the rectum. The 
data acquisition parameters [38] are shown in Table 1.
The reference standard of prostate cancer foci in the MR images was established through a 
systematic consensus-seeking correlative review of histological findings and MR images by 
a genitourinary pathologist (with 8 years of experience in genitourinary pathology) and a 
radiologist (with 9 years of experience in prostate MR imaging). The pathologist sliced each 
prostate and identified all distinct tumor foci larger than approximately 5 mm in diameter, 
and then the radiologist manually outlined the corresponding ROIs of the tumor foci on the 
MR images according to the tumor regions on the histological slices by the pathologist. 
Totally, 1–3 cancer delineations on MR images of each subject were cooperatively done 
manually by radiologist and the pathologist. Note that these cancer ROIs were mostly 
outlined on T2 images, and some were outlined on DW images.
We resampled all images into the size of 512 × 512 with the resolution of 0.3125 mm × 
0.3125 mm × 3 mm. For the alignment, since the dADC image was generated from DWI, we 
need only to align DWI and dADC images to T2 image for each subject. Through our 
experiments, we found that the results of registration affected the final voxel level 
classification, e.g., better registration leads to better cancer region localization. We also 
found that the linear registration method can meet requirements in our work due to no large 
deformation occurring among multi-parametric MR images of each subject. Here, we use 
the FMRIB’s linear image registration tool (FLIRT) [39] to implement this procedure. 
However, since the contrast of the prostate and other tissues in DWI and dADC is not high 
enough while the boundary of bladder is obvious, we first align T2 image to DWI along with 
the bladder masks, and then align DWI to T2 image with the prostate masks. Histogram 
matching [40] was also performed on each type of MRI across different subjects.
2.2. Prostate cancer localization with random forests and auto-context model
In our method, we formulate the localization of prostate cancer as a two-class classification 
problem. To solve such a classification problem, we proposed a novel learning-based multi-
source integration framework by employing random forests [31] and auto-context model 
[32,33]. For simplicity, let Nsub be the total number of the training subjects and let 
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 be a set of multi-parametric MRIs. As a supervised 
learning method, our method consists of both training and testing stages. The flowchart of 
training stage is shown in Fig. 2. In the training stage, we will train a sequence of 
classification forests, each with the input of multi-source images/maps. In the first iteration, 
the classification forest takes only the multi-parametric MRIs I as input, and uses the image 
appearance features extracted from different multi-parametric MRIs for voxel-wise 
classification. By applying the trained forest in the first iteration, each ith training subject 
will produce tissue probability maps for prostate cancer  and non-prostate cancer , 
respectively, as shown in the second column of Fig. 2. In the later iterations, as inspired by 
the auto-context model [32,33], the tissue probability maps 
obtained from the previous iteration will act as additional source information for training. 
Specifically, the high-level context features are extracted from the tissue probability maps to 
assist the classification, along with appearance features from the multi-parametric MRIs. 
Since context features are informative about the nearby tissue structures for each voxel, they 
encode the spatial constraints into the classification, thus improving the quality of the 
estimated tissue probability maps, as also demonstrated in Fig. 2. Then, the tissue 
probability maps are iteratively updated and fed into the next training iteration. Finally, a 
sequence of learned classifiers will be obtained.
Similarly, in the testing stage, given a target subject with multi-parametric MRIs, we can 
obtain the initial tissue probability map by applying the trained classifier in the first iteration 
using only the multi-parametric MRIs. In the later iterations, along with multi-parametric 
MRIs, the tissue probability maps resulted from the previous iteration are also fed into the 
next classifier for refinement. Fig. 3(a)–(c) shows examples by applying a sequence of the 
learned classifiers for cancer localization in the PZ, CG, and TZ, respectively. As we can see 
from Fig. 3, the cancer probability maps are updated with iterations and become more and 
more accurate. In the following, we will detail on how to train the classifiers via random 
forests.
2.3. Random forests
Random forest [31] is an ensemble learning method for classification or regression. As a 
machine learning method, random forest has been successfully applied in many fields, such 
as bioinformatics, computer vision, and medical image analysis [41,42].
In our work, we employ random forest to implement cancer localization for a given testing 
voxel x, based on its high-dimensional feature representation f(x,I), where I is a set of multi-
parametric MR images as we define in the above. When the random forest is implemented, 
at each iteration, totally T decision trees, indexed by t ∈ [1, T], are used as classification 
trees. In the training stage, in the first iteration, each tree t learns a weak class predictor pt(c|
f(x, I)) using features extracted from a set of multi-parametric MR images I, where c is the 
label of cancer or non-cancer. When the training stage starts, according to the feature 
representation, the training samples are assigned to the left and right child nodes at each 
parent node through recursive splitting. At each node, to obtain the optimal split for 
maximizing the information gain [43], a number of random splits on different combinations 
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of features and thresholds are considered. The tree keeps growing until it reaches the 
constraint conditions. For example, it reaches a specified depth (d), or the criterion that no 
tree leaf node should contain less than a certain number of training samples (smin). Finally, 
we associate each leaf node (l) with the empirical distribution  over the two 
classes by the proportions of the labels of all training samples which reach that leaf node.
In the testing stage, by applying the learned split functions, each testing voxel x is 
independently tested. When the testing sample arrives at a leaf node lx in each trained tree t, 
the empirical distribution of that leaf node is used to determine the class probability of the 
testing sample x, i.e., . Finally, we can obtain the class 
probability for the testing sample x by computing the mean of the class probabilities from all 
individual trees, i.e., . In our work, what we should solve is a 
two-class classification problem. Therefore, in the trained random forest, for each ith 
training subject at the first iteration, only cancer and non-cancer probability maps 
( ) are generated, as shown in the second column of Fig. 2.
2.4. Appearance features and context features
Random forest can deal with a large number of features efficiently. In other words, for 
random forest, in our study, any kind of features from multi-parametric MRI and tissue 
probability maps can be extracted and used for classification, such as the histogram of 
oriented gradients (HOG) features [44], local binary pattern (LBP) features [45], Gabor 
features [46], and any kind of gradient features [47]. In fact, in our implementation, 
considering the efficiency, we use the random Haar-like features [48] for both appearance 
features and context features. Note that the Haar-like features have been used widely in 
many studies of pattern recognition or machine learning [49–51]. Specifically, for each voxel 
x, its Haar-like features are computed as the local mean intensity of any randomly displaced 
cubical region R1 or the mean intensity difference over any two randomly displaced, 
asymmetric cubical regions (R1 and R2) within the image patch R [52]:
(2)
where R is the patch centered at voxel x, I is any kind of source image, and the parameter b 
∈ {0, 1} indicates whether one or two cubical regions are used (as shown in Fig. 4, for b = 0 
and b = 1). In the image patch R, its intensities are normalized to the unit ℓ2 norm [53,54]. In 
theory, for each voxel we can determine an infinite number of such features.
3. Experimental results and analysis
In this section, the proposed method will be extensively evaluated on 26 subjects using 
leave-one-out cross-validation. Results of the proposed method are compared with the 
manual ground-truth segmentations, as well as other conventional methods.
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3.1. Evaluation methods
In the following, we mainly employ the section-based evaluation (SBE) [55], sensitivity, 
specificity, and Dice ratio, to measure the performances of different methods.
3.1.1. Section-based evaluation (SBE)—Section-based evaluation (SBE) is defined as 
a ratio of the number of the sections that automatic method localizes correctly to the number 
of the total sections that the prostate is divided into:
(3)
(4)
where label(·) in Eq. (3) represents that the section is cancer or non-cancer; As and Bs are the 
localization results of the section s through automatic method and expert, respectively; and n 
is the number of the total sections that the prostate is divided into.
The SBE is an effective method widely used for evaluating the performance of the prostate 
cancer section localization. Generally, in the clinical setting, when a patient is diagnosed as a 
suspicious prostate cancer sufferer with a high PSA level or an abnormal screening DRE, a 
biopsy is frequently suggested [56]. Often, when doing a biopsy, the prostate is divided into 
sections based on the number of biopsy points to use, followed by shooting a needle in each 
section to extract the respective tissue sample. A popular way is to divide prostate into 6 
sections (for 6 point biopsy) [57]: right base, left base, right mid, left mid, right apex, and 
left apex. Alternatively, some doctors will choose 12 sections by further dividing each of 
these 6 sections into medial and lateral parts. This method is very popular in prostate cancer 
diagnosis in clinic, and it is also the standard of the prostate biopsy, as shown in the 
schematic diagram at the top of Fig. 5. However, 6- or 12-sections partition does not 
consider the shape of prostate. We take a typical slice of the mid part of the prostate as an 
example in Fig. 6. The 1st row and 2nd row show the division results on a MRI slice with 6-
section division and 12-section division, respectively. It can be seen that the 6- or 12-section 
division will generate too large section for a biopsy needle, which may result in more shots 
to different points in each section for accurate extraction of cancer tissue. To reduce the 
number of the locations for biopsy in each section while still keeping the accuracy of 
cancerous section localization, we divide the prostate into sections by considering the size of 
each prostate part (base, mid-gland and apex). In general, as shown in the bottom of Fig. 5, 
the base and mid parts of the prostate are divided into 9 sections, while the apex is divided 
into 4 sections. For a typical prostate slice mentioned above, the division result is shown in 
the 3rd row of Fig. 6. It can be observed that, by dividing the prostate into these fine 
sections, we can more accurately localize cancer sections, compared with the conventional 
6- and 12-section partition strategies.
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3.1.2. Sensitivity and specificity—We employ two important statistical measures: 
sensitivity and specificity. Here, besides the standard voxel-wise definitions of sensitivity 
and specificity, we also reformulate the sensitivity and specificity based on the divided 
prostate sections:
(5)
(6)
where TCS is the number of true localized cancerous sections, FNS is the number of 
cancerous sections localized as normal sections, TNS is the number of true localized normal 
sections, and FCS is the number of normal sections localized as cancerous sections.
3.1.3. Dice ratio—Dice ratio [58] measures the overlap between our localized cancer 
region and the ground-truth cancer region. The Dice ratio is formulated as:
(7)
where Ipre is our predicted cancer region and Igrd is the ground-truth cancer region.
3.2. Parameters setting
In the random forest training, the number of classification trees is 20; the maximum tree 
depth is 50; the number of randomized Haar-like features is 10,000 for both image 
appearance and context features; and the minimum sample number for each leaf node is 8. 
These parameters are determined via cross-validation. Specifically, we first study the impact 
of the number of trees, T, on cancer section localization, as shown in Fig. 7(a). We set the 
maximal tree depth as 50 and the minimal number of leaf nodes as 8 according to previous 
work [59]. In Fig. 7(a), the SBE increases from 0.66 (T = 2) to 0.87 (T = 15), the standard 
deviation decreases from 0.030 (T = 2) to 0.013 (T = 15), and the cancer localization 
performance tends to be stable when T ≥ 20. Therefore, to produce reasonable and accurate 
results, we set T = 20 in our work. Fig. 7(b) shows the impact of the maximum tree depth. 
We find that the SBE gradually increases as the depth varying from 5 to 20 and then 
becomes stable as the depth reaches over 40. Fig. 7(c) shows the impact of the minimum 
sample number for each leaf node. The performance becomes stable when the minimum 
sample number is less than 8, while the performance starts decreasing when the minimum 
sample number is larger than 10. The possible reason is that the samples with cancer label 
and the samples with non-cancer label fall into the same leaf node because of setting too 
large value for the minimum sample number in each leaf node, which results in fuzzy 
classification. As for the number of iterations, we find that the satisfactory performance can 
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be achieved in 3 or 4 iterations, and, after that, the performance becomes stable. In this 
paper, we conservatively set the iteration number as 10, to obtain both effectiveness and 
accuracy for our proposed method.
3.3. Feature types
In our work, we choose the random Haar-like features for the appearance features and 
context features. To demonstrate the advantage of random Haar-like features, we make 
comparisons with other four types of features: HOG features [44], LBP features [45], Gabor 
features [46] and gradient features [47]. As shown in Table 2, we can find that the sensitivity 
with random Haar-like feature is a little bit lower than that with LBP feature, and also the 
specificity with random Haar-like feature is lower than that with HOG feature. However, the 
overall performance with random Haar-like feature is much better than the respective 
performances with other four types of features.
3.4. Importance of context features
In the proposed method, the context features play an important role. They can improve the 
accuracy of localization iteratively. Fig. 8 and Table 3 show the SBEs of our sections 
division on 26 patient subjects by sequentially applying the learned classifiers based on the 
multi-parametric MR images. It can be seen that the SBEs are improved with the iterations 
and also become stable after a few iterations. Specially, in the second iteration, the SBEs are 
improved greatly due to the integration of the previously estimated tissue probability maps 
for guiding the classification. These results demonstrate the importance of using context 
features for cancer localization.
The sensitivity and specificity of our cancer section localization with iterations are also 
shown in Table 3. It can be seen that there is a decrease, followed by an increase of both 
sensitivity and specificity with the increasing number of iterations. The main reason is that, 
in the first iteration, when no cancer probability maps are available, most of the localized 
cancer regions are larger than the ground truth, i.e., by the example shown in the second 
column of Fig. 2 and the example shown in Fig. 3(b); thus the sensitivity is higher and 
specificity is lower. With the increase of iterations, the localized cancer regions shrink and 
the final localized cancer regions become smaller than the ground truth, resulting in the 
decrease of sensitivity while increase of specificity. We can also find that the specificity is 
improved from 81.3% to 84.1% in the second iteration.
From Table 3, it can be seen that the section-based sensitivity and specificity, respectively, 
achieve the relative high values, i.e., 91.5% and 85.1%, with a few iterations. This means 
that almost no any cancer section is localized as non-cancer section and also most of the 
non-cancer sections are correctly localized. To verify the accuracy of cancer region 
localization with our method for potentially guiding biopsy, two typical prostate slices are 
taken as examples. For the first example shown in Fig. 9(a), our method can accurately 
localize cancer regions. For another example shown in Fig. 9(b), it can be seen that our 
method can not only localize the true cancer region but also provide another suspicious 
cancer region; both of these localized cancer regions are suspicious, which need to be tested 
by biopsy needle. However, compared with the traditional biopsy, in the second example, the 
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number of sections to place the biopsy needle is the same, but the accuracy of localizing 
cancer sections is largely improved because of adoption of fine section division. Therefore, 
the proposed method with our section division method is very useful to guide prostate 
biopsy, which can reach a considerable performance gain by reducing the number of 
suspicious cancer sections as well as guaranteeing the accuracy of cancer section 
localization.
3.5. Performance of combining multi-parametric MRI
In the past decade, many studies have shown the improvement of cancer diagnosis or 
detection accuracy with combination of different types of MRI. For example, Wang et al. 
[60] and Kim et al. [61] validated that the single modality MRI, T2 or ADC map can be used 
for cancer detection. But the information from the single modality MRI is not rich enough to 
better differentiate cancer region from normal tissue. To illustrate the superior performance 
of cancer detection using multi-parametric MRI, we compared the performances using 
different combinations of image modalities as shown in Fig. 10. The SBE by combining all 
T2, DWI and dADC is 87.1%, which is better than the results obtained by any of other six 
combination cases (T2: 76.8%; DWI: 80.4%; dADC: 83.2%; T2 + dADC: 86.8%; T2 + 
DWI: 80.6%; DWI + dADC: 86.5%). By comparing the results only with single modality 
MRI, we can see that the performance of using dADC in prostate cancer localization is 
better than that of using either T2 or DWI, demonstrating that ADC map can provide more 
useful information for prostate cancer localization. Since ADC map is computed from DWI, 
these results also provide the evidence as concluded in [27–29]: DWI has outperformance 
over other existing MRI in prostate cancer localization and detection.
3.6. Comparisons with conventional methods
Due to the unavailability of codes and dataset, we cannot perform a fair comparison with 
other state-of-the-art prostate cancer localization methods. Therefore, in this section, we 
compared our method with other classification-based methods on the same dataset. More 
specifically, we compare the proposed method with four popular classification methods: (1) 
Naïve Bayes classifier [62], (2) Support Vector Machine (SVM) [63], (3) SVM with radial 
basis function (RBF) kernel (SVM + RBF) [64], and (4) AdaBoost [65], as detected below. 
In these methods, to achieve the best performance, we extract not only the Haar-like 
features, but also the HOG features [44], LBP features [45], Gabor features [46] and 
gradient features [47].
• Naïve Bayes classifier technique is based on the so-called Bayesian theorem, and 
is particularly well-suited when the dimensionality of the inputs is high. Despite 
its simplicity, Naïve Bayes classifier can often outperform more sophisticated 
classification methods. In the training stage, using a set of training samples, the 
method estimates the parameters of a probability distribution (i.e., Gaussian 
distribution), by assuming that features are conditionally independent given the 
class. In other words, all model parameters (i.e., class priors and feature 
probability distributions) can be approximated with the relative frequencies from 
the training samples. In the testing stage, for any unseen test sample, this method 
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computes the posterior probability of that sample belonging to each class, and 
then classifies the test sample according to the largest posterior probability.
• Support Vector Machine (SVM) is a supervised learning model associated with 
learning algorithms that analyze data and recognize patterns, which can be used 
for classification and regression. It is often used for solving two-class 
classification problem. Given a set of training samples, each belonging to one of 
the two categories, an SVM training algorithm builds a model, i.e., generating 
two optimal hyperplanes to separate the input samples into two categories and 
also preventing the samples from falling into the maximum margin (i.e., the gap 
between the hyperplanes). For the parameter setting, we choose the linear 
function and RBF as two candidate kernel functions and set both cost functions 
as 1, and the parameter gamma in RBF kernel is set as 1/k, where k is the 
number of training samples. Then, the learning model is generated by training 
the input training samples. Before training and testing, for each sample, 500 
discriminant features among all features are selected using feature selection 
method (such as Fisher Score [66]). In the application stage, the generated model 
is used for cancer prediction in the testing image.
• AdaBoost has been a mature and popular machine learning method for 
classification for decades. When training the input samples, it generates a series 
of weak learners by updating the weight on each training sample. At each 
iteration, a weak learner is selected and assigned with a coefficient such that the 
sum of training error of the boosting classifiers is minimized. These weak 
learners finally converge to a strong learner. We set the maximum number of 
iterations as 200 in the weak learner refining process to build a strong classifier. 
Finally, the generated classifier is used in the testing stage and then the tissue 
probability map is obtained.
Fig. 11 shows the comparison results using the four methods on the multi-parametric MR 
images of the same patient as shown in Fig. 6. The results of Naïve Bayes, SVM, SVM + 
RBF, AdaBoost and our proposed method are shown in the 1st, 2nd, 3rd, 4th and 5th rows, 
respectively, and further indicated by the orange, brown, cyan, green and blue contours. The 
1st, 2nd and 3rd columns represent the localization results with T2, DWI and dADC images, 
respectively. It can be observed that the result of proposed method is much better than other 
four methods, and is very similar to the ground truth. In the localization maps of other three 
methods except SVM + RBF, the localized cancer regions are noisy, which could result in 
more non-cancer regions localized as the suspicious cancer regions for guiding needle 
placement. In contrast, from the 5th row, we can see that, by using the proposed method, the 
localized cancer region is clear. On the other hand, for the result with SVM + RBF, although 
the localized cancer region is also clear, it is much smaller than the ground truth, and is also 
not as good as the result obtained by our proposed method.
3.6.1. SBE, sensitivity and specificity—For quantitative evaluation, the SBE, 
sensitivity and specificity on 26 subjects are shown in Table 4, which further illustrates the 
outperformance of the proposed method over other four methods. Specifically, the average 
SBE (87.1%), sensitivity (91.5%) and specificity (85.1%) of the proposed method are much 
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higher than those by any of other four methods: (1) SBE 68.5%, sensitivity 73.7% and 
specificity 65.9% by Naïve Bayes; (2) SBE 71.4%, sensitivity 72.6% and specificity 71.0% 
by SVM; (3) SBE 79.9%, sensitivity 66.1% and specificity 83.8% by SVM + RBF; (4) SBE 
68.0%, sensitivity 94.6%, and specificity 60.5% by AdaBoost. It can be seen that the SBE 
and specificity by our proposed method are significantly higher than those by Naïve Bayes, 
SVM, SVM + RBF and AdaBoost method. The sensitivity by the proposed method is 
slightly smaller than that by AdaBoost, but still much better than that by Naïve Bayes, SVM 
and SVM + RBF, respectively. All these results again demonstrate the performance of our 
proposed method than other four conventional methods.
3.6.2. Common ROC and ROI-based ROC analysis—To better validate the proposed 
method, we further employ the receiver operating characteristic (ROC) analysis method 
[67]. We use two kinds of ROC analysis methods. One is the common ROC analysis method 
[67,68] and the other is the ROI-based ROC analysis method [69].
The ROC curve is used to analyze the performance of a classifier system in many research 
fields, such as medicine, radiology, biometrics, machine learning and data mining [67]. The 
common ROC curve is built by analyzing the results from each testing subject. It illustrates 
the relationship between the true positive rate and the false positive rate at various threshold 
settings. On the other hand, the ROI-based ROC analysis was proposed by Obuchowski et al. 
[69]. They used it to detect and locate breast cancers. They partitioned the images into 
several ROIs. Every reader assigned a confidence score to each ROI. Finally, they used the 
ROI-based ROC analysis to access the reader’s ability of detecting and locating the 
abnormalities. In our work, we also use the ROI-based ROC analysis to evaluate the 
performance of our method. We divide the images into sections as shown in the bottom of 
Fig. 5. We choose the maximum value from the probabilities of all voxels in a section as the 
confidence score of each section, which results in localization of all suspicious cancer 
sections as well as fully convinced non-cancer ones, thus ensuring both accuracy and 
precision of cancer-section localization. We also calculate the area under the ROC curve 
(AUC) which can evaluate a classifier system quantitatively.
Fig. 12(a) shows common ROC curves, and Fig. 12(b) shows ROI-based ROC curves. The 
blue curve illustrates the ROC of our proposed method. As we can see from Fig. 12(a), along 
with the AUC value (0.832), our proposed method produces slightly better than that obtained 
by Naïve Bayes method, but much better than other three methods. These results indicate 
that our method can localize cancer voxels very well. Furthermore, as we can see from Fig. 
12(b), along with the area under the ROI-based ROC curve (0.883), our proposed method 
has obvious superiority over other four methods.
In addition, to evaluate the effectiveness of our method on individual patients, we apply two 
different ROC analysis methods to the localization results with five different methods on 26 
patients. Fig. 13(a) shows the AUC values on 26 patients by the proposed method, Naïve 
Bayes, SVM, SVM + RBF, and AdaBoost methods. Most of the AUC values by our method 
are over 0.7, with the highest as 1.0, which indicates that our method works well in cancer 
voxel localization for the same individual patient. From Fig. 13(b), we can observe that most 
of the AUC values under the ROI-based ROC curves by our proposed method are over 0.8, 
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which are better than those achieved by Naïve Bayes, SVM, SVM + RBF and AdaBoost 
methods on 26 patients. These results further validate the effectiveness of our proposed 
method in cancer section localization.
3.6.3. Mean Dice ratio—To evaluate the performance of our method for the cancer 
localization in different zones, we calculate the mean Dice ratios in PZ, CG and TZ, 
respectively. The average Dice ratios are shown in Table 5. It can be observed that our 
method achieves higher average Dice ratios 62.0% in PZ, 56.7% in CG and 78.0% in TZ 
than other four methods.
4. Discussions
In this paper, we have proposed a fully automatic method for prostate cancer localization. In 
previous works, most methods [8,14] involve a semi-automatic identification process, i.e., 
pre-outlining the suspicious cancer ROIs by experts and then classifying the ROIs into 
cancer or non-cancer. Another limitation of most existing methods is that they focused on 
cancer identification only in the PZ, such as [9,10,15]. In MR images, cancers in the PZ have 
richer and discriminative textural imaging signatures compared with those in the CG [17] 
and TZ [18,19], which makes cancer detection in the PZ easier than that in the CG and TZ. 
In contrast, in our study, we localize the cancer regions in the whole prostate. Other existing 
methods [17,26–28,60,61,70,71] mainly focused on classification of the manually delineated 
ROIs as cancer or normal tissue, which is subject to the accuracy of manual experts and also 
labor-intensive and time-consuming.
Another difference in our study is that we currently aim to guide prostate biopsy through the 
cancer localization method. Using our localized cancer regions, the clear shooting path to 
the cancer region could be designed and also the accuracy of biopsy could be improved 
significantly. Additionally, our method can also be used in other applications, such as focal 
therapy planning, triage and follow-up of patients with active surveillance, and decision 
making in treatment selection.
Compared with the works of other researchers, such as [6], there are two limitations in our 
study: (1) the number of subjects is limited. In [6], totally 165 patients with cancer were 
included. In our study, only 26 patients were validated. To overcome this limitation, in our 
experiments, we detected over 100 thousand samples from totally 26 subjects and used voxel 
level classification method. (2) For each prostate image in our study, cancer ROIs are 
outlined only on 1–3 discontinuous slices. For some special cancer regions, such as with low 
Gleason scores, the number of such regions is small and the extracted appearance 
information is relatively little for localizing or discriminating them from the surrounding 
normal tissues. This actually causes some cancer ROIs not accurately localized by our 
method.
In fact, our method can also be extended to other cancer/tumor localization or identification 
with some adjustment of parameters. For example, we have applied our method to high-
grade brain tumor localization. We use 20 subjects from the BRATS 2013 [72] off-site 
dataset, where each subject has four modality images, including Flair, T2, T1c and T1 MR 
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images. All of these subjects are annotated by 4 doctors. We set the number of tree as 10; the 
maximum depth of tree as 100; the number of randomized Haar-like features as 5000; and 
the patch size as 31 × 31 × 31. We use the Dice ratio to evaluate our method, and obtain the 
mean Dice ratio of 0.768. The best result is 0.802. It can be seen that our method also 
achieves a reasonable result on brain tumor localization, which can be further improved in 
the future.
5. Conclusion
We have proposed a novel framework to localize prostate cancer regions in the in vivo MR 
images. Our proposed method can directly localize cancer regions from the entire images. 
Specially, we employ random forests and auto-context model to effectively integrate features 
from multi-parametric MRI and also the iteratively-estimated probability maps for cancer 
localization. Experimental results on 26 real patient data show that our method can 
accurately localize cancer regions, which will be useful for potentially guiding the needle 
biopsy, targeting the tumor in focal therapy planning, triage and follow-up of patients with 
active surveillance, and decision making in treatment selection. In our future work, we will 
further validate our proposed method on more patient subjects.
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Fig. 1. 
T2, DWI, and dADC images are used for cancer localization. In the 2nd row, the prostate 
boundary and cancer region are indicated by the yellow contour and red contour, 
respectively. (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of the article.)
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Fig. 2. 
Flowchart of the training procedure for our proposed method with multi-source images, i.e., 
T2, DWI and dADC MR images, along with cancer probability maps. The appearance 
features from multi-parametric MR images are used for training the first classifier, and then 
both appearance features and the context features from probability maps are employed for 
training the subsequent classifiers.
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Fig. 3. 
Three typical examples, showing the performances of applying the proposed method to 
cancer localization in (a) PZ, (b) CG, and (c) TZ. We use the trained classifier from multi-
parametric MRIs in the first iteration to obtain the initial tissue probability maps. Then, in 
the later iterations, the tissue probability maps resulted from previous iteration are also fed 
into the next classifier for refinement.
Qian et al. Page 22
Comput Med Imaging Graph. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 4. 
Computation of Haar-like features. The red rectangle indicates the patch centered at voxel x. 
Haar-like features are computed as the local mean intensity of any randomly displaced 
cubical region R1, or the mean intensity difference over any two randomly displaced, 
asymmetric cubical regions (R1 and R2) within the image patch R. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of the 
article.)
Qian et al. Page 23
Comput Med Imaging Graph. Author manuscript; available in PMC 2017 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 5. 
Schematic diagram of the conventional prostate division (i.e., 6-section division and 12-
section division) and our section division.
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Fig. 6. 
Different section division methods for a typical prostate slice. Here, the prostate is divided 
by pink dashed lines. The red contour indicates the manual segmentation of the cancer ROI, 
and yellow contour represents the prostate boundary. The slice is divided into 2, 4 and 9 
parts, respectively. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of the article.)
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Fig. 7. 
Influences of (a) the number of classification trees, (b) the maximal depth of trees and (c) 
the minimum sample number in each leaf node.
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Fig. 8. 
Improvement of SBE with classification iterations. Specifically, in the second iteration, the 
SBE is improved greatly, and, after a few iterations, it tends to be stable at around 87%.
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Fig. 9. 
Two examples of cancer section localization by our method. Prostate is divided by pink 
dashed lines. Yellow contour indicates the prostate boundary. Red contours indicate the 
manual delineations, and blue contours indicate the localization results with our method. 
(For interpretation of the references to color in this figure legend, the reader is referred to the 
web version of the article.)
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Fig. 10. 
The SBE values obtained by using different combinations of multi-parametric MRI. The 
result by combining all T2, DWI and dADC images is the best, compared to other six 
combinations.
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Fig. 11. 
Comparison of cancer localization results by Naïve Bayes, SVM, SVM + RBF, AdaBoost, 
and the proposed method, on a typical prostate slice also as shown in Fig. 6. The yellow 
contour indicates the prostate region. The red contour indicates manual segmentation, along 
with the automated segmentation results by Naïve Bayes, SVM, SVM + RBF, AdaBoost, 
and our proposed method indicated by the orange, brown, cyan, green, and blue contours, 
respectively. (For interpretation of the references to color in this figure legend, the reader is 
referred to the web version of the article.)
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Fig. 12. 
(a) Common ROC curves; (b) ROI-based ROC curves. (For interpretation of the references 
to color in this figure legend, the reader is referred to the web version of the article.)
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Fig. 13. 
(a) Comparison of AUC values among the proposed method, Naïve Bayes, SVM, SVM + 
RBF, and AdaBoost methods on 26 patients. Most of AUC values are over 0.7 and the 
highest is 1.0 by our proposed method. (b) Comparison of AUC values under the ROI-based 
ROC curves by the proposed method, Naïve Bayes, SVM, SVM + RBF, and AdaBoost on 
26 patients. Most AUC values by our proposed method are over 0.8. (For interpretation of 
the references to color in this figure legend, the reader is referred to the web version of the 
article.)
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Table 3
SBE, sensitivity and specificity of our cancer section localization with respect to different number of 
iterations.
Iteration SBE Sensitivity Specificity
1 (first cancer probability map) 0.844 0.941 0.813
2 0.866 0.928 0.841
3 0.865 0.915 0.841
4 0.867 0.915 0.846
5 0.867 0.915 0.846
6 0.867 0.915 0.846
7 0.869 0.909 0.851
8 0.868 0.896 0.851
9 0.871 0.915 0.851
10 0.871 0.915 0.851
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Table 4
SBE, sensitivity and specificity of cancer section localization with five different methods on 26 subjects.
Method SBE Sensitivity Specificity
Naïve Bayes 0.685 0.737 0.659
SVM 0.714 0.726 0.710
SVM + RBF 0.799 0.661 0.838
AdaBoost 0.680 0.946 0.605
Proposed 0.871 0.915 0.851
The number in “bold” font indicates the best result achieved by different methods in terms of SBE, Sensitivities, and Specificity.
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